Skip to main content
Carna Biosciences, Inc. logo

Carna Biosciences, Inc. — Investor Relations & Filings

Ticker · 4572 ISIN · JP3220550002 T Manufacturing
Open in API
Filings indexed 77 across all filing types
Latest filing 2025-08-07 Interim / Quarterly Rep…
Country JP Japan
Listing T 4572

About Carna Biosciences, Inc.

https://www.carnabio.com/

Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of small molecule kinase inhibitors. The company focuses on creating therapies for diseases with significant unmet medical needs, particularly in oncology and autoimmune disorders. Carna Biosciences operates through two core segments: a drug discovery business that advances its proprietary pipeline of drug candidates, and a drug discovery support business. The support division provides the global research community with a comprehensive portfolio of products and services, including a wide array of kinase proteins, biochemical and cell-based screening, and profiling services to accelerate pharmaceutical research and development.

Recent filings

Filing Released Lang Actions
半期報告書－第23期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Kinki Local Finance Bureau in Japan, covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, management analysis (MDA), and business status reports. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) is classified as an Interim/Quarterly Report (IR). H1 2025
2025-08-07 Japanese
有価証券届出書（組込方式）
Capital/Financing Update Classification · 98% confidence The document is titled "有価証券届出書" (Securities Registration Statement) and is submitted to the "近畿財務局長" (Director of Kinki Local Finance Bureau). It details the terms for the issuance of "新株予約権付社債" (Bonds with Stock Acquisition Rights), specifically the "第３回無担保転換社債型新株予約権付社債" (3rd Unsecured Convertible Bonds with Stock Acquisition Rights). This type of filing, which registers the offering of securities (debt with equity features) with regulatory authorities in Japan, corresponds to a registration statement for a capital/financing activity. Among the provided codes, "CAP" (Capital/Financing Update) is the most appropriate fit for a detailed securities registration related to issuing convertible bonds, as it covers company fundraising and capital structure changes. It is not a general Annual Report (10-K), an Earnings Release (ER), or a simple announcement (RPA/RNS), given its comprehensive nature and specific regulatory context.
2025-07-11 Japanese
有価証券届出書（組込方式）
Capital/Financing Update Classification · 98% confidence The document is titled "有価証券届出書" (Securities Registration Statement) and is submitted to the Kinki Local Finance Bureau Director ("近畿財務局長"). It details the issuance terms for "新株予約権付社債" (Bonds with Stock Acquisition Rights), specifically the "第２回無担保転換社債型新株予約権付社債" (2nd Unsecured Convertible Bond Type with Stock Acquisition Rights). This type of comprehensive filing detailing the terms of a new security offering, including pricing, interest rates, redemption methods, and conversion formulas, is characteristic of a registration statement filed with financial regulators in Japan for a public offering or private placement of securities. This aligns best with the category for financing activities, which is 'Capital/Financing Update' (CAP), although in a US context, this would be an S-1 or similar registration. Given the provided definitions, 'CAP' is the most appropriate fit for a document detailing the terms of a new bond issuance/fundraising activity.
2025-07-11 Japanese
有価証券届出書（組込方式）
Capital/Financing Update Classification · 98% confidence The document text is in Japanese and contains structured information typical of a securities filing. Key phrases include "有価証券届出書" (Securities Registration Statement), "提出先：近畿財務局長" (Filing Destination: Director of Kinki Local Finance Bureau), and details about the issuance of "新株予約権付社債" (Convertible Bonds with Stock Acquisition Rights). This structure and content strongly indicate a formal regulatory filing related to capital raising or debt issuance, specifically a registration statement for convertible bonds. Among the provided codes, 'CAP' (Capital/Financing Update) is the most appropriate category as it deals directly with fundraising and capital structure changes via the issuance of convertible bonds. While it is a formal filing, it is not a standard SEC form like 10-K, nor is it a general announcement (RPA/RNS); it is a specific financing document.
2025-07-11 Japanese
臨時報告書
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a Japanese regulatory filing, indicated by the header information (e.g., 【提出書類】臨時報告書, 【提出先】近畿財務局長, 【提出日】2025年3月28日). The content explicitly details the resolutions passed at a General Shareholders' Meeting (株主総会) held on March 25, 2025, including the election of directors and capital reduction proposals, along with the voting results (賛成数, 反対数, 決議の結果). This structure perfectly matches the definition of reporting the results of a general meeting. The code for Declaration of Voting Results & Voting Rights Announcements is DVA.
2025-03-28 Japanese
内部統制報告書－第22期(2024/01/01－2024/12/31)
Governance Information Classification · 100% confidence The document contains Japanese text with headers like "【提出書類】 内部統制報告書" (Filing Document: Internal Control Report) and references to the Financial Instruments and Exchange Act ("金融商品取引法"). It explicitly discusses the assessment of internal controls over financial reporting ("財務報告に係る内部統制の評価"). This structure and content strongly indicate a formal report on internal controls, which aligns best with the Audit Report / Information category (AR), as it deals with internal controls and assurance, distinct from a full Annual Report (10-K) or a simple Earnings Release (ER). Although the Japanese term is 'Internal Control Report', in the provided schema, 'AR' (Audit Report / Information) is the closest fit for reports detailing internal control assessments and applied accounting principles/results of tests.
2025-03-26 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.